A Virtual Reality View of Biologic Agents: Targeted Therapies for the Management of Moderate-to-Severe Atopic Dermatitis in Adults

REGISTER NOW!
Already Registered?
SIGN IN

This symposium is an independently organized event and not an official part of the 13th Annual Coastal Dermatology Symposium.

WEBCAST DATE

THURSDAY, OCTOBER 5, 2017

7:45 PM Eastern    6:45 PM Central    5:45 PM Mountain    4:45 PM Pacific

Faculty

Zelma Chiesa Fuxench, MD, MSCE, FAAD
Assistant Professor of Dermatology
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

• Explain how dysfunctional immunologic factors and pathways provide potential biomarkers and targets for treatment in adult patients with moderate-to-severe AD
• Discuss best practices for the assessment and diagnosis of moderate-to-severe AD in adult patients, accounting for biomarkers, comorbidities, and disease burden
• Describe the MOAs and clinical trial safety data associated with targeted biologic agents in development for the treatment of adults with AD

TARGET AUDIENCE

This activity is intended for US-based dermatologists, allergists/immunologists, primary care physicians, pharmacists, and nurses involved in the management of adult patients with atopic dermatitis.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 1.0 AMA Category 1 Credit(s)^TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Purpose:

This program would be beneficial for nurses involved in the long-term treatment and management of patients with atopic dermatitis.

Credits: 1.0 ANCC Contact Hour(s)

Accreditation Statement:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hour(s) of continuing nursing education of RNs and APNs.

AAD RECOGNIZED CREDIT STATEMENT

The Med Learning Group Virtual Reality View of Biologic Agents: Target Therapies for the Management of Moderate-to-Severe Atopic Dermatitis in Adults (Program #65502) is recognized by the American Academy of Dermatology for 1 AAD Recognized Credit(s) and may be used toward the American Academy of Dermatology's Continuing Medical Education Award.

AAPA ACCREDITATION

This program has been reviewed and is approved for a maximum of 1.0 AAPA Category 1 CME credits by the AAPA Review Panel. PAs should claim only those credits actually spent participating in the CME activity. 

This program was planned in accordance with AAPA CME Standards for Live Programs and for Commercial Support of Live Programs.


 

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

Copyright © 2017 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.